Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Reverse Merger Gives Rexahn Listing On OTC Bulletin Board

May 17, 2005

By Jennifer Boggs

Onyx, Bayer Begin Phase III Sorafenib Trial In Melanoma

May 16, 2005

By Jennifer Boggs

Spherics Gets $26M To Push Bioadhesive Drug Delivery

May 13, 2005

By Jennifer Boggs

Spherics Gets $26M To Push Bioadhesive Drug Delivery

May 13, 2005

By Jennifer Boggs

Executives Discuss Goals Of Strategic Partnering, Licensing

May 12, 2005

By Jennifer Boggs

Biotech firms finding 2005 IPO, venture funding a tough sell

May 12, 2005

By Jennifer Boggs

Executives Discuss Goals Of Strategic Partnering, Licensing

May 12, 2005

By Jennifer Boggs

Investors Discuss Funding Options In Difficult Market

May 11, 2005

By Jennifer Boggs

Investors Discuss Funding Options In Difficult Market

May 11, 2005

By Jennifer Boggs

By Advancing GSK Agreement, Exelixis Gets $35M In Milestones

May 10, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 31, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Cell mapping yields clues to metabolic health in obese individuals
BioWorld
Researchers at the University of Leipzig and ETH Zurich have used single-cell sequencing to identify differences between fat tissue of obese individuals who are...
Ionis notches Arrowhead win; Tryngolza cleared for FCS
BioWorld
Ionis Pharmaceuticals Inc. CEO Brett Monia predicted that diagnoses of familial chylomicronemia syndrome (FCS) will “accelerate fairly quickly” now that the firm...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.